Microparticles for lung delivery comprising diketopiperazine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6071497
SERIAL NO

08847352

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Drug delivery to the pulmonary system has been achieved by encapsulation of the drug to be delivered in microparticles having a size range between 0.5 and ten microns, preferably in the range of two to five microns, formed of a material releasing drug at a pH of greater than 6.4. In a preferred embodiment, the drug delivery system is based on the formation of diketopiperazine microparticles which are stable at a pH of 6.4 or less and unstable at pH of greater than 6.4, or which are stable at both acidic and basic pH, but which are unstable at pH between about 6.4 and 8. Other types of materials can also be used, including biodegradable natural and synthetic polymers, such as proteins, polymers of mixed amino acids (proteinoids), alginate, and poly(hydroxy acids). In another embodiment, the microparticles have been modified to effect targeting to specific cell types and to effect release only after reaching the targeted cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • PHARMACEUTICAL DISCOVERY CORPORATION

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Feldstein, Robert Dobbs Ferry, NY 27 1846
Lian, Huiling Yonkers, NY 4 482
Rhodes, Christopher A Stamford, CT 21 823
Shen, Gregory S Hartsdale, NY 10 732
Steiner, Solomon S Mt. Kisco, NY 79 4210

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation